In this section

Get in contact with us








Back

Human primary cellular assays

Using human primary cell assays as a basis, we have developed a platform for efficient and disease-relevant target discovery.

For each disease program, we screen our adenoviral collections in functional assays to identify genes that regulate the disease. These hits are passed through a series of increasingly complex validation assays to test the biological relevance of the targets. Further assays are carried out to eliminate off-target hits.

These validated targets can be used as starting points for a drug discovery program.

If you would like to know more about our services, discuss custom assays, specific research, or get a quote, please contact us.

Past target discovery programs

We have over ten years’ experience using human primary and disease-relevant cell assays in the following fields:

  • Allergic rhinitis
  • Asthma
  • Alzheimer’s disease
  • Atherosclerosis
  • Cancer
  • Cystic fibrosis
  • Huntington’s disease
  • Inflammation and immunology
  • Obesity
  • Osteoarthritis
  • Osteoporosis
  • Psoriasis
  • Rheumatoid arthritis




Print to HTML Print as PDF Send to a friend




BioFocus®, SoftFocus®, Galapagos®, SilenceSelect® and FLeXSelect® ThemePair™, FieldFocus™, HDRA™. Helical Domain Recognition Analysis™, 2D Roadmap™, Thematic Analysis™, SFK™, SFI™, SFG™ and PrimePath™ are trademarks of Galapagos NV and/or its affiliates.